2005

1. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

   Neurobiology of Disease, Vol. 20, Núm. 2, pp. 207-217